Literature DB >> 10435043

Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases.

R Cospedal1, H Abedi, I Zachary.   

Abstract

OBJECTIVE: Phosphatidylinositol 3'-kinase (PI3-kinase) is implicated in cell migration and focal adhesion kinase (FAK) phosphorylation. In contrast, it has been proposed that mitogen-activated protein (MAP) kinases are essential for proliferation but may be dissociated from chemotactic signalling. We investigated the roles of PI3-kinase and p42/p44 MAP kinases in cell migration and FAK tyrosine phosphorylation induced by platelet-derived growth factor-BB (PDGF-BB) in rabbit aortic vascular smooth muscle cells (VSMCs). The roles of PI3-kinase and MAP kinase pathways in the chemotactic response to insulin-like growth factor-I (IGF-I) were also examined.
METHODS: The roles of PI3-kinase and p42/p44 MAP kinases were assessed using the PI3-kinase inhibitors, wortmannin and LY294002, and an inhibitor of MAP kinase kinase, PD98059. PI3-kinase activity was measured by phosphatidylinositol phosphorylation in anti-phosphotyrosine immunoprecipitates and by thin layer chromatography of phosphorylated products. Phosphorylation was assessed by immunoprecipitation with anti-phosphotyrosine antibodies and Western blotting with FAK-specific antibody. Migration was evaluated in a chemotaxis chamber using polycarbonate filters with an 8-mm pore size.
RESULTS: Neither wortmannin nor LY294002 significantly reduced PDGF-BB stimulation of FAK tyrosine phosphorylation, chemotaxis or immunofluorescent staining of focal adhesions in VSMCs. PD98059, a specific inhibitor of MAP kinase activation, did not inhibit FAK tyrosine phosphorylation but markedly inhibited the migratory response of VSMCs to PDGF-BB. IGF-I also stimulated migration of VSMCs, and, relative to the effect of PDGF-BB, induced smaller increases in PI3-kinase and MAP kinase activities. Both wortmannin and PD98059 partially inhibited the migratory response to IGF-I.
CONCLUSIONS: PDGF-BB stimulation of both FAK tyrosine phosphorylation and migration in VSMCs are not dependent on activation of PI3-kinase. While PDGF-BB stimulation of FAK tyrosine phosphorylation is not dependent on p42/p44 MAP kinase activation, PDGF-BB and IGF-I both stimulate p42/p44 MAP kinase activity and the chemotactic response to these factors is partially dependent on MAP kinase activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435043     DOI: 10.1016/s0008-6363(98)00232-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  Substrate-induced phenotypic switches of human smooth muscle cells: an in vitro study of in-stent restenosis activation pathways.

Authors:  Anna L Guildford; Helen J S Stewart; Christopher Morris; Matteo Santin
Journal:  J R Soc Interface       Date:  2010-11-24       Impact factor: 4.118

2.  The role of myeloid cell-derived PDGF-B in neotissue formation in a tissue-engineered vascular graft.

Authors:  Ekene Onwuka; Cameron Best; Andrew Sawyer; Tai Yi; Eric Heuer; Malik Sams; Matthew Wiet; Hong Zheng; Themis Kyriakides; Christopher Breuer
Journal:  Regen Med       Date:  2017-05-19       Impact factor: 3.806

3.  Interstitial flow induces MMP-1 expression and vascular SMC migration in collagen I gels via an ERK1/2-dependent and c-Jun-mediated mechanism.

Authors:  Zhong-Dong Shi; Xin-Ying Ji; Danielle E Berardi; Henry Qazi; John M Tarbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-30       Impact factor: 4.733

4.  Platonin inhibited PDGF-BB-induced proliferation of rat vascular smooth muscle cells via JNK1/2-dependent signaling.

Authors:  Yi Chang; Yih-Huei Uen; Chang-Chih Chen; Song-Chow Lin; Shiao-Yun Tseng; Yi-Hsuan Wang; Joen-Rong Sheu; Cheng-Ying Hsieh
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

5.  Chlorotyrosine promotes human aortic smooth muscle cell migration through increasing superoxide anion production and ERK1/2 activation.

Authors:  Hong Mu; Xinwen Wang; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Atherosclerosis       Date:  2008-02-20       Impact factor: 5.162

6.  Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells.

Authors:  Marpadga A Reddy; Saurabh Sahar; Louisa M Villeneuve; Linda Lanting; Rama Natarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-18       Impact factor: 8.311

7.  Nitrotyrosine promotes human aortic smooth muscle cell migration through oxidative stress and ERK1/2 activation.

Authors:  Hong Mu; Xinwen Wang; Peter Lin; Qizhi Yao; Changyi Chen
Journal:  Biochim Biophys Acta       Date:  2008-05-05

Review 8.  PI3K at the crossroads of tumor angiogenesis signaling pathways.

Authors:  Adriana Soler; Ana Angulo-Urarte; Mariona Graupera
Journal:  Mol Cell Oncol       Date:  2015-02-26

9.  MicroRNA-182 prevents vascular smooth muscle cell dedifferentiation via FGF9/PDGFRβ signaling.

Authors:  Nana Dong; Wei Wang; Jinwei Tian; Zulong Xie; Bo Lv; Jiannan Dai; Rui Jiang; Dan Huang; Shaohong Fang; Jiangtian Tian; Hulun Li; Bo Yu
Journal:  Int J Mol Med       Date:  2017-02-22       Impact factor: 4.101

10.  A Tubing-Free Microfluidic Wound Healing Assay Enabling the Quantification of Vascular Smooth Muscle Cell Migration.

Authors:  Yuanchen Wei; Feng Chen; Tao Zhang; Deyong Chen; Xin Jia; Junbo Wang; Wei Guo; Jian Chen
Journal:  Sci Rep       Date:  2015-09-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.